Medical content standards
Rules we use when writing about a prescription medicine on an educational website.
Last updated: August 20, 2026
What is known, what is labeled, what is uncertain
Pages should make those three layers visible. FDA-approved indications are listed as labeled uses for a named product. Off-label prescribing is described as a clinical practice, not as a secret approval. Mechanism language follows the label, including statements that the precise mechanism is unknown.
No personalized instructions
We may summarize labeled titration examples as examples that belong to a product insert. We will not tell a reader how many milligrams to take, generate a taper, or collect weight to calculate a dose. Kidney adjustment tables in labeling are for clinicians; reproducing them as a public calculator would invite unsafe self-service.
Safety without sensationalism
Warnings about breathing, mood, driving, and allergic reactions are included because they are labeled, not to frighten. Emergency signs are stated plainly. We avoid “completely safe,” “cures,” “works for everyone,” and similar absolutes unless a source actually supports a carefully scoped statement—which, for gabapentin, they generally do not.
Product identity
Immediate-release gabapentin, Gralise, and Horizant are treated as distinct. We do not imply milligram-for-milligram substitution across those products.
Commerce
The site must not facilitate purchasing, compare pharmacies for obtaining gabapentin, or praise “no prescription” access. Educational discussion of why those offers are unsafe is allowed.
Authorship
See the editorial policy. We will not invent a medical reviewer to look more trustworthy.